121% revenue growth for FY18 across the business globally, strong cash position and minimal debt, increased working capital to support ongoing growth, investment for expected future growth...wow, ive been following following exl all along and i must say what a promising diversified company to be invested in. With a CEO at the helm with over 20 years experience in the industry and a firm believer in his market leading products, this is enough to keep me excited!
- Forums
- ASX - By Stock
- EXL
- Ann: FY 2018 Investor Results Presentation
Ann: FY 2018 Investor Results Presentation, page-4
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EXL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.605M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $1.605K | 321.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 6265944 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 14532474 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3797 | 4.490 |
1 | 8000 | 4.480 |
2 | 6000 | 4.470 |
1 | 358 | 4.460 |
3 | 3424 | 4.450 |
Price($) | Vol. | No. |
---|---|---|
4.500 | 31 | 1 |
4.510 | 342 | 1 |
4.520 | 397 | 1 |
4.530 | 370 | 1 |
4.540 | 825 | 2 |
Last trade - 15.57pm 25/11/2024 (20 minute delay) ? |
Featured News
EXL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online